You are here:
botulinum toxin type A (Xeomin®)
Advice
following an abbreviated submission
botulinum toxin type A (Xeomin®) is accepted for use within NHS Scotland.
Indication under review: post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults.
In patients for whom botulinum toxin, type A is an appropriate choice of therapy, this offers an alternative formulation to the comparator product containing conventional botulinum toxin, type A complex.
Drug Details
| Drug Name: | botulinum toxin type A (Xeomin®) |
|---|---|
| SMC Drug ID: | 731/11 |
| Manufacturer: | Merz Pharma UK Ltd |
| Indication: | Post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults. |
| BNF Category: | |
| Sub Category: | 4.9 Drugs used in Parkinsonism and related disorders |
| Submission Type: | Abbreviated Submission |
| Status: | Accepted |
| Date Advice Published: | 10 October 2011 |